Enzychem Lifesciences Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Ki-Young Sohn
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | 4.8% |
| Management average tenure | no data |
| Board average tenure | 7.2yrs |
Recent management updates
CEO
Ki-Young Sohn
no data
Tenure
Ki-Young Sohn serves as the Chairman and Chief Executive Officer at Enzychem Lifesciences Corporation. Ki-Young Sohn holds MBA from graduate School of Business, Dept. of Business Administration Korea Unive...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & Chief Executive Officer | no data | no data | 4.78% ₩ 8.0b | |
| Member of Corporate Advisory Committee & CTO | 2.3yrs | no data | no data | |
| Chief Scientific Officer & Member of the Board of Directors | no data | no data | no data | |
| CMO & Director | 7.2yrs | no data | no data | |
| Executive Director | no data | no data | no data | |
| VP & Executive Director | no data | no data | no data | |
| Director | 7.2yrs | no data | no data | |
| Vice Chairman | no data | no data | 0.075% ₩ 125.5m | |
| Director | 7.2yrs | no data | no data | |
| Director | 7.2yrs | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Chairman of Scientific Advisory Board | no data | no data | no data |
7.2yrs
Average Tenure
70yo
Average Age
Experienced Board: A183490's board of directors are considered experienced (7.2 years average tenure).